Holding(s) in Company

RNS Number : 4539M

Dechra Pharmaceuticals PLC

29 January 2009

 



For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

DECHRA PHARMACEUTICALS

2. Reason for notification (yes/no)
An acquisition or disposal of voting rights	YES
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________

3. Full name of person(s) subject to notification obligation:	SCHRODERS PLC
4. Full name of shareholder(s) (if different from 3):
5. Date of transaction (and date on which the threshold is crossed or reached if different):	27.01.09
6. Date on which issuer notified:	28.01.09
7. Threshold(s) that is/are crossed or reached:	FROM 12% - 13%

8: Notified Details
A: Voting rights attached to shares
Class/type of shares If possible use ISIN code	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of shares	Number of voting rights	Number of shares	Number of voting rights		Percentage of voting rights
				Direct	Indirect	Direct	Indirect
ORDINARY GB0009633180	8,269,752	7,863,622	9,213,868	N/A	8,596,908	N/A	13.13%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ conversion period/date	No. of voting rights that may be acquired (if the instrument exercised/converted)	Percentage of voting rights

Total (A+B)
Number of voting rights	Percentage of voting rights
8,596,908	13.13%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

SCHRODER INVESTMENT MANAGEMENT LIMITED             7,885,783    12.04% SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA LIMITED                                                                          711,125     1.09%

Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements
14 Contact name:	ANDREA ROWE
15. Contact telephone number:	020 7658 6000

For notes on how to complete form TR-1 please see the FSA website. 

 

END

 

 

HOLFGGZMGLNGLZM